In the new ear of MS drugs, safety has been an important consideration. The risk of cancer in patients treated with IFNs has been raised, although never proven. In this issue of JNNP, a large study from British Columbia categoricaly excludes the association of any cancers with MS. Interestingly, there was a non-signifcant increase in the risk of breast cancer, most likely a chance occurence.
Must read more at: http://jnnp.bmj.com/content/85/10/1096.abstract
- Multiple sclerosis
- Research paper